ReposiTrak (TRAK) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
14 May, 2026Executive summary
Achieved a strategically important quarter with a focus on touchless traceability, filing two new patents and deploying solutions at major grocery and wholesale customers, reinforcing competitive moats and expanding the patent portfolio to nine U.S. patents.
Transitioned to a highly scalable SaaS platform with over 98% recurring revenue, improving predictability and quality of earnings, and recurring revenue grew across all business lines.
Formed a collaboration with SPAR Group to extend capabilities from issue identification to in-store remediation, addressing a key industry bottleneck and enhancing supply chain solutions.
Net income for the quarter was $2 million, essentially flat year-over-year, with operating income up 24% and a continued focus on recurring subscription revenue.
Traceability solutions are a key growth driver, supported by regulatory changes and industry mandates.
Financial highlights
Q3 fiscal 2026 revenue was $5.9 million, flat year-over-year, with nine-month revenue up 5% to $17.7 million.
Operating expenses decreased 12% year-over-year to $3.6 million; income from operations rose 24% to $2.3 million.
GAAP net income for the quarter was $2 million; nine-month net income reached $5.5 million, up 6% year-over-year.
Ended the quarter with $26.4 million in cash and zero bank debt; working capital at $26.3 million.
Operating cash flow for the first nine months was $5.9 million.
Outlook and guidance
Priorities remain on disciplined execution, recurring revenue growth, profitability expansion, prudent capital allocation, and long-term shareholder value.
Management expects continued growth in recurring subscription revenue and traceability demand, driven by regulatory and commercial adoption.
Expect financial impact from the SPAR partnership to be visible in six to nine months.
Ongoing preferred share redemptions expected to be completed by December 2026.
Modeling an effective tax rate of approximately 20% going forward.
Latest events from ReposiTrak
- Q2 revenue up 7%, EPS up 13%, strong cash, no debt, and leadership in traceability.TRAK
Q2 202617 Feb 2026 - Record revenue, net income, and cash with accelerating traceability and higher dividends.TRAK
Q4 202420 Jan 2026 - Traceability and retailer mandates drove 8% revenue growth and a 10% dividend increase.TRAK
Q1 202513 Jan 2026 - Deferred revenue up 70% and double-digit growth expected, fueled by traceability demand.TRAK
Q2 202523 Dec 2025 - Director elections, auditor ratification, and executive pay aligned with performance highlight the meeting.TRAK
Proxy Filing1 Dec 2025 - Preliminary proxy statement filed, detailing voting matters and shareholder procedures.TRAK
Proxy Filing1 Dec 2025 - Annual meeting covers director elections, executive pay, auditor ratification, and governance.TRAK
Proxy Filing1 Dec 2025 - Preliminary proxy outlines voting items and governance for the upcoming shareholder meeting.TRAK
Proxy Filing1 Dec 2025 - Q3 revenue up 16% and net income up 27%, with strong recurring revenue and cash flow.TRAK
Q3 202526 Nov 2025